290 related articles for article (PubMed ID: 3127975)
1. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
Christensen JE; Larsen AB; Gregersen G
Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
[No Abstract] [Full Text] [Related]
2. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
[TBL] [Abstract][Full Text] [Related]
3. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
Christensen JE; Varnek L; Gregersen G
Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibition for diabetic neuropathy.
Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
[No Abstract] [Full Text] [Related]
5. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Hotta N; Sakamoto N
Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
[No Abstract] [Full Text] [Related]
6. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.
Jaspan JB; Towle VL; Maselli R; Herold K
Metabolism; 1986 Apr; 35(4 Suppl 1):83-92. PubMed ID: 3083212
[TBL] [Abstract][Full Text] [Related]
7. Can aldose reductase inhibition ameliorate diabetic neuropathy?
González ER
JAMA; 1981 Sep; 246(11):1169-70. PubMed ID: 6790734
[No Abstract] [Full Text] [Related]
8. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
Jaspan JB; Herold K; Bartkus C
Am J Med; 1985 Nov; 79(5A):24-37. PubMed ID: 3000176
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of aldose reductase in human diabetic neuropathy.
Jaspan J
Drugs; 1986; 32 Suppl 2():23-9. PubMed ID: 2431859
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil.
O'Hare JP; Morgan MH; Alden P; Chissel S; O'Brien IA; Corrall RJ
Diabet Med; 1988 Sep; 5(6):537-42. PubMed ID: 2974776
[TBL] [Abstract][Full Text] [Related]
11. Review of myo-inositol and sorbinil studies.
Clements RS
Clin Physiol; 1985; 5 Suppl 5():90-3. PubMed ID: 3938689
[No Abstract] [Full Text] [Related]
12. Medical therapy in the prevention of cataract.
Brown NA; Bron AJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
[TBL] [Abstract][Full Text] [Related]
13. Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.
Lewin IG; O'Brien IA; Morgan MH; Corrall RJ
Diabetologia; 1984 Jun; 26(6):445-8. PubMed ID: 6432615
[TBL] [Abstract][Full Text] [Related]
14. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
15. Prolonged aldose reductase inhibition in chronic peripheral diabetic neuropathy: effects on microangiopathy.
Jennings PE; Nightingale S; Le Guen C; Lawson N; Williamson JR; Hoffman P; Barnett AH
Diabet Med; 1990 Jan; 7(1):63-8. PubMed ID: 2137066
[TBL] [Abstract][Full Text] [Related]
16. Six-month treatment with sorbinil in asymptomatic diabetic neuropathy. Failure to improve abnormal nerve function.
Martyn CN; Reid W; Young RJ; Ewing DJ; Clarke BF
Diabetes; 1987 Sep; 36(9):987-90. PubMed ID: 3111914
[TBL] [Abstract][Full Text] [Related]
17. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
Yue DK; Hanwell MA; Satchell PM; Turtle JR
Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients.
Judzewitsch RG; Jaspan JB; Polonsky KS; Weinberg CR; Halter JB; Halar E; Pfeifer MA; Vukadinovic C; Bernstein L; Schneider M; Liang KY; Gabbay KH; Rubenstein AH; Porte D
N Engl J Med; 1983 Jan; 308(3):119-25. PubMed ID: 6401351
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiological variables and fibrinolysis in insulin-dependent diabetes treated with an aldose reductase inhibitor or placebo. A double-blind randomized study.
Jespersen J; Gram J; Christensen JE
Haemostasis; 1986; 16(6):453-7. PubMed ID: 3108105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
